Dynavax Technologies | Salg

Sales Lave om Dato
AbbVie USD 14.3B 374M 2023-12
Adma Biologics USD 73.9M 6.63M 2023-12
Amgen USD 8.2B 1.29B 2023-12
AstraZeneca USD 12.02B 532M 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Dynavax Technologies USD 55.6M 13.92M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Merck USD 14.63B 1.33B 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
TG Therapeutics USD 43.97M 121.84M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Dynavax Technologies Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.